APA (7th ed.) Citation

Backus, L. I., Belperio, P. S., Shahoumian, T. A., Loomis, T. P., & Mole, L. A. (2016). Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice. Alimentary Pharmacology & Therapeutics, 44(4), 400. https://doi.org/10.1111/apt.13696

Chicago Style (17th ed.) Citation

Backus, L. I., P. S. Belperio, T. A. Shahoumian, T. P. Loomis, and L. A. Mole. "Comparative Effectiveness of Ledipasvir/sofosbuvir ± Ribavirin Vs. Ombitasvir/paritaprevir/ritonavir + Dasabuvir ± Ribavirin in 6961 Genotype 1 Patients Treated in Routine Medical Practice." Alimentary Pharmacology & Therapeutics 44, no. 4 (2016): 400. https://doi.org/10.1111/apt.13696.

MLA (9th ed.) Citation

Backus, L. I., et al. "Comparative Effectiveness of Ledipasvir/sofosbuvir ± Ribavirin Vs. Ombitasvir/paritaprevir/ritonavir + Dasabuvir ± Ribavirin in 6961 Genotype 1 Patients Treated in Routine Medical Practice." Alimentary Pharmacology & Therapeutics, vol. 44, no. 4, 2016, p. 400, https://doi.org/10.1111/apt.13696.